Lataa...
Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
Olanzapine is the one of first line antipsychotic drug for schizophrenia and other serious mental illness. However, it is associated with troublesome metabolic side-effects, particularly body weight gain and obesity. The antagonistic affinity to histamine H(1) receptors (H(1)R) of antipsychotic drug...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Public Library of Science
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4118967/ https://ncbi.nlm.nih.gov/pubmed/25084453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0104160 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|